---
title: "Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289234884.md"
description: "Gilead Sciences (GILD) shares fell 2.03% to $125.50 on Tuesday, marking its third consecutive day of losses and underperforming competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories. The stock remains 20.21% below its 52-week high. Trading volume reached 8.6 million, exceeding the 50-day average."
datetime: "2026-06-09T20:35:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289234884.md)
  - [en](https://longbridge.com/en/news/289234884.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289234884.md)
---

# Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Gilead Sciences Inc. (GILD) slid 2.03% to $125.50 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.17% to 50,872.11 and the S&P 500 Index falling 0.26% to 7,386.65.

This was the stock's third consecutive day of losses.

Gilead Sciences Inc. closed 20.21% short of its 52-week high of $157.29, which the company achieved on February 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 2.08% to $237.00, Pfizer Inc. (PFE) rose 0.31% to $25.70, and Abbott Laboratories (ABT) rose 0.83% to $91.25.

Trading volume (8.6 M) eclipsed its 50-day average volume of 6.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 9, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

06-09-26 1635ET

### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

- [Gilead Sciences, Inc. $GILD Shares Sold by BI Asset Management Fondsmaeglerselskab A S](https://longbridge.com/en/news/288924413.md)
- [Gilead And Lakefront Acquire Ouro Medicines In $1.67 Bln Agreement; To Co-Develop Gamgertamig](https://longbridge.com/en/news/288851463.md)
- [Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa | GILD Stock News](https://longbridge.com/en/news/288820076.md)
- [Gilead Advances Liver Disease Ambitions With Encouraging Study Outcome](https://longbridge.com/en/news/288463750.md)
- [Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline | GILD Stock News](https://longbridge.com/en/news/288769642.md)